Market Cap (intraday)5: 363.37M Enterprise Value (Jan 6, 2015)3: 431.98M Trailing P/E (ttm, intraday): N/A Forward P/E (fye Dec 31, 2015)1: 17.20 PEG Ratio (5 yr expected)1: N/A Price/Sales (ttm): 1.37 Price/Book (mrq): 0.79 Enterprise Value/Revenue (ttm)3: 1.63 Enterprise Value/EBITDA (ttm)6: 3.42
shows it has more debt than cash and about 9 times mkt cap of CLGRF, so thus about 1/4th the production per dollar of investment compared to CLGRF http://finance.yahoo.com/q/ks?s=clgrf&ql=1
LSG does have good EV/EBITDA, BUT SINCE 9 TIMES MKT CAP BUT JUST TWICE The EBITDA it appears about 1/4 as good a value investment as CLGRF
Income Statement clgrf
Revenue (ttm): 71.77M Revenue Per Share (ttm): 0.39 Qtrly Revenue Growth (yoy): 62.40% Gross Profit (ttm): -3.02M EBITDA (ttm)6: 77.75M Net Income Avl to Common (ttm): -19.25M Diluted EPS (ttm): -0.11
Think if you compare all the #s CLGRF shines as the cheaper of two compared to earnings and growth. Not knocking LSG just highlighting CLGRF value. Yahoo can not calculate EV/EBITDA for Claude but it is about 0.8, outrageously good.